Key Record Dates
ClinicalTrials.gov Identifier: | NCT05619172 |
---|---|
Brief Title: | A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer |
First Submitted : | November 1, 2022 |
First Submitted that Met QC Criteria : | November 8, 2022 |
First Posted : | November 16, 2022 |
Last Update Submitted that Met QC Criteria : | March 6, 2024 |
Last Update Posted : | March 7, 2024 |